High-energy Flux Density Extracorporeal Shock-wave Therapy Versus
                    Therapeutic Steroid Injection in Costochondritis: A Single-Blind, Randomised
                    Controlled Study

Halil Çiftçi; Ömer Gezginaslan

doi:10.1055/a-1180-8053

Aktuelle Rheumatologie, Table of Contents

Aktuelle Rheumatologie 2021; 46(01): 80-87
DOI: 10.1055/a-1180-8053

Original Article

High-energy Flux Density Extracorporeal Shock-wave Therapy Versus Therapeutic Steroid Injection in Costochondritis: A Single-Blind, Randomised Controlled Study

Extrakorporale Stoßwellentherapie mit hoher Energieflussdichte im Vergleich zur therapeutischen Steroidinjektion bei Costochondritis: Eine einfach blinde, randomisierte, kontrollierte Studie

Halil Çiftçi

¹Thoracic Surgery, University of Health Sciences, Umraniye Training and Research Hospital, Istanbul, Turkey

,

Ömer Gezginaslan

²Physical Therapy and Rehabilitation, University of Health Sciences, Umraniye Training and Research Hospital, Istanbul, Turkey

› Author Affiliations

Abstract

Background This study aims to investigate the effects of extracorporeal shock-wave therapy (ESWT) and intra-articular steroid injection (IASI) on pain, depression, quality of life and pressure pain threshold (PPT) in patients with costochondritis.

Methods A total of 67 patients diagnosed with costochondritis were included. Patients were divided into 2 groups. Group 1 (n=34) received high-energy flux density (H-ESWT) (> 0.28 mJ/mm²) for a total of 7 sessions at 3-day intervals. Group 2 (n=33) received IASI twice at 2-week intervals. At baseline and one month after treatment, Visual Analog Scale (VAS), Short Form-36 (SF-36), Pittsburgh Sleep Quality Index (PSQI), Beck Depression Inventory (BDI) scores and PPT values were compared.

Results There was a statistically significant decrease in VAS scores after treatment compared with baseline scores in both groups. The PPT and SF-36 subscale scores were also statistically significantly higher (p<0.05). After treatment, VAS and PPT showed a significantly better improvement in Group 1 compared to Group 2. There was a significant correlation between VAS and SF-36 physical functioning as well as pain subscales in Group 1 and a significant correlation between VAS and SF-36 physical functioning in Group 2.

Conclusions Our data suggest that both treatments H-ESWT and IASI are effective in costochondritis patients. Of note, H-ESWT has a stronger effect on pain and PPT scores.

Zusammenfassung

Hintergrund Ziel dieser Studie ist es, die Auswirkungen der extrakorporalen Stoßwellentherapie (ESWT) und der intraartikulären Steroidinjektion (IASI) auf Schmerzen, Depressionen, Lebensqualität und Druckschmerzschwelle (PPT) bei Patienten mit Costochondritis zu untersuchen.

Methoden Insgesamt wurden 67 Patienten mit der Diagnose einer Costochondritis eingeschlossen. Die Patienten wurden in 2 Gruppen eingeteilt. Gruppe 1 (n=34) erhielt für insgesamt 7 Sitzungen in 3-tägigen Intervallen eine hochenergetische Flussdichte (H-ESWT) (> 0,28 mJ/mm²). Gruppe 2 (n=33) erhielt 2-mal im Abstand von 2 Wochen IASI. Zu Studienbeginn und einen Monat nach der Behandlung wurden die Werte für Visual Analog Scale (VAS), Short Form-36 (SF-36), Pittsburgh Sleep Quality Index (PSQI), Beck Depression Inventory (BDI) und PPT-Werte verglichen.

Ergebnisse Es gab eine statistisch signifikante Abnahme der VAS-Werte nach der Behandlung im Vergleich zu den Ausgangswerten in beiden Gruppen. Die Subskalenwerte für PPT und SF-36 waren ebenfalls statistisch signifikant höher (p<0,05). Nach der Behandlung zeigten VAS und PPT eine signifikant größere Verbesserung in Gruppe 1 im Vergleich zu Gruppe 2. Es bestand ein signifikanter Zusammenhang zwischen der VAS und der körperlichen Funktionsfähigkeit nach SF-36, sowie Schmerz-Subskalen in Gruppe 1 und eine signifikante Korrelation zwischen der VAS und der körperlichen Funktionsfähigkeit nach SF-36 in Gruppe 2.

Schlussfolgerungen Unsere Daten deuten darauf hin, dass sowohl die H-ESWT als auch die IASI-Behandlung bei Patienten mit Costochondritis wirksam sind. Die H-ESWT hat dabei eine stärkere Wirkung auf Schmerzen und PPT-Scores.

Keywords

costochondritis - extracorporeal shock-wave therapy - quality of life - pressure pain threshold - intra-articular steroid injection

Schlüsselwörter

Costochondritis - Extrakorporale Stoßwellentherapie - Intraartikuläre Steroid injection - Lebensqualität - Druckschmerzschwelle

Full Text

References

References
1 Schumann JA, Parente JJ. Costochondritis. StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2019. Jan–2019 Dec 11
2 Disla E, Rhim HR, Reddy A. et al. Costochondritis. A prospective analysis in an emergency department setting. Arch Intern Med 1994; 154: 2466-2469
3 Semble EL, Wise CM. Chest pain: a rheumatologist’s perspective. South Med J 1988; 81: 64-68
4 How J, Volz G, Doe S. et al. The causes of musculoskeletal chest pain in patients admitted to hospital with suspected myocardial infarction. Eur J Intern Med 2005; 16: 432-436
5 Spalding L, Reay E, Kelly C. Cause and outcome of atypical chest pain in patients admitted to hospital. J R Soc Med 2003; 96: 122-125 DOI: 10.1258/jrsm.96.3.122
6 Pan PJ, Chou CL, Chiou HJ. et al. Extracorporeal shock wave therapy for chronic calcific tendinitis of the shoulders: a functional and sonographic study. Arch Phys Med Rehabil 2003; 84: 988-993
7 Perlick L, Schiffmann R, Kraft CN. et al. Extracorporal shock wave treatment of the achilles tendinitis: Experimental and preliminary clinical results. Z Orthop Ihre Grenzgeb 2002; 140: 275-280
8 Ordahan B, Türkoğlu T, Karahan AY. et al. Extracorporeal shockwave therapy versus kinesiology taping in the management of plantar fascitis: a randomized clinical trial. Arch Rheumatol 2017; 32: 227-233
9 Ottoman C, Hartmann B, Tyler JH. et al. Prospective randomized trial of accelerated re-epithelization of skin graft donor sites using extracorporeal shock wave therapy. J Am Coll Surg 2010; 211: 361-367
10 Rompe JD, Hope C, Küllmer K. et al. Analgesic effect of extracorporeal shock-wave therapy on chronic tennis elbow. J Bone Joint Surg Br 1996; 78: 233-237
11 Gallagher EJ, Liebman M, Bijur PE. Prospective validity of clinically important changes in pain severity measured on visual analog scale. Ann Emerg Med 2001; 38: 633-638
12 Collins SL, Moore RA, McQuay HJ. The visual analogue pain intensity scale: what is moderate pain in millimetres?. Pain 1997; 72: 95-97
13 Koçyiğit H, Aydemir Ö, Fişek G. et al. Reliability and validity of the Turkish version of short form-36. İlaç ve Tedavisi Dergisi 1999; 2: 12
14 Sahin NH. Use of the beck depression inventory with Turkish university students: reliability, validity and factor analysis. Turkish. Journal of Psychology 1989; 7: 3-1322
15 Oxlund H. The Influence of a local injection of cortisol on the mechanical properties of tendons and ligaments and the indirect effect on skin. Acta Orthopaedica Scandinavica 1980; 51 1–6 231-238
16 Ostergaard M, Halberg P. Intra-articular corticosteroids in arthritic disease: a guide to treatment. BioDrugs 1998; 9: 95-103
17 Zimmermann R, Cumpanas A, Miclea F. et al. Extracorporeal shock wave therapy for the treatment of chronic pelvic pain syndrome in males: a randomised, double-blind, placebo-controlled study. Eur Urol 2009; 56: 418-424
18 Hausdorf J, Lemmens MA, Heck KD. et al. M. Selective loss of unmyelinated nerve fibers after extracorporeal shockwave application to the musculoskeletal system. Neuroscience 2008; 155: 138-144
19 Hausdorf J, Lemmens MA, Kaplan S. et al. Extracorporeal shock wave application to the distal femur of rabbits diminishes the number of neurons immunoreactive for substance P in dorsal root ganglia L5. Brain Res 2008; 1207: 96-101
20 Rompe JD, Furia J, Weil L. et al. Shock wave therapy for chronic plantar fasciopathy. Br Med Bull 2007; 81-82: 183-208
21 Gollwitzer H, Diehl P, Von Korff A. et al. Extracorporeal shock wave therapy for chronic painful heel syndrome: a prospective, double blind, randomized trial assessing the efficacy of a new electromagnetic shock wave device. J Foot Ankle Surg 2007; 46: 348-357
22 Liang HW, Wang TG, Chen WS. et al. Thinner plantar fascia predicts decreased pain after extracorporeal shock wave therapy. Clin Orthop Relat Res 2007; 460: 219-225
23 Verstraelen FU, In den Kleef NJ, Jansen L. et al. High-energy versus low-energy extracorporeal shock wave therapy for calcifying tendinitis of the shoulder: which is superior? A meta-analysis. Clin Orthop Relat Res 2014; 472: 2816-2825
24 Thiel M. Application of shock waves in medicine. Clin Orthop Relat Res 2001; 387: 18-21
25 Müller-Ehrenberg H, Licht G. Diagnosis and therapy of myofascial pain syndrome with focused shock waves (ESWT). Med Orthop Tech 2005; 5: 1-6
26 Gür A, Koca İ, Karagüllü H. et al. Comparision of the effectiveness of two different extracorporeal shockwave therapy regimens in the treatment of patients with myofascial pain syndrome. Arch Rheumatol 2014; 29: 186-193
27 Park KD, Lee WY, Park MH. et al. High- versus low-energy extracorporeal shock-wave therapy for myofascial pain syndrome of upper trapezius: a prospective randomized single blinded pilot study. Medicine(Baltimore) 2018; 97: e11432
28 Chow IH, Cheing GL. Comparison of different energy densities of extracorporeal shock wave therapy (ESWT) for the management of chronic heel pain. Clin Rehabil 2007; 21: 131-141
29 Wang YC, Chen SJ, Huang PJ. et al. Efficacy of different energy levels used in focused and radial extracorporeal shockwave therapy in the treatment of plantar fasciitis: a meta-analysis of randomized placebo-controlled trials. J Clin Med 2019; 8 pii: E1497